This content is machine translated EHA 2025 Progress in multiple myeloma The annual meeting of the European Hematology Association (EHA) has been one of the most important focal points for international haematology for many years. With more than 15,000 participants on...…
View Post 6 min This content is machine translated Cutaneous and especially facial metastases Rare manifestations of esophageal carcinoma Cutaneous metastases are among the rarest manifestations of esophageal carcinoma and occur in less than 1% of cases. Even more unusual is the occurrence in the face, which has so...…
View Post 14 min This content is machine translated Prevention of skin cancer UV protection and skin cancer screening – Update 2025 The number of new cases of skin cancer has risen sharply in recent years. Melanomas are less common than basal cell and squamous cell carcinomas, but account for around 70%...… CME-Test
View Post 5 min This content is machine translated An emerging interface with clinical relevance Lung cancer and neuroscience Lung cancer is still the leading cause of cancer-related mortality worldwide. In addition to established risk factors such as tobacco consumption and molecular alterations, the interaction between tumors and the...…
View Post 5 min This content is machine translated Acute leukemia: Disease management Priorities from the perspective of patients and family caregivers Studies launched by the patient organization ALAN (The Acute Leukemia Advocates Network) map patient preferences in acute leukemia on the one hand and record the situation of relatives involved in...…
View Post 5 min This content is machine translated New perspectives for the optimization of cancer immunotherapy Nanoparticle-mediated intratumoral gene editing of PD-L1 and galectin-9 Immune checkpoint inhibitors (ICI) have revolutionized oncological therapy, but many patients do not respond or only respond inadequately to this form of treatment. Resistance mechanisms such as the overexpression of...…
View Post 7 min This content is machine translated From genome profiles to targeted therapies Advances in breast cancer therapy in the age of molecular diagnostics The treatment of breast cancer has undergone a profound transformation over the last two decades. While clinical-pathological parameters long formed the sole basis for therapy decisions, molecular diagnostics and personalized...…
View Post 6 min This content is machine translated Update on diagnostics, risk stratification and therapy Acute myeloid leukemia 2025 Acute myeloid leukemia (AML) remains one of the greatest challenges in hematology. Despite established chemotherapy protocols, the prognosis for many patients remains unfavorable. In recent years, however, new molecular classifications,...…
View Post 16 min This content is machine translated Blastic plasmacytoid dendritic cell neoplasia Rare malignancy from a dermatological perspective Blastic plasmacytoid dendritic cell neoplasia (BPDCN) is an aggressive hematologic malignancy originating from immature plasmacytoid dendritic cell (PDC) precursors. The initial manifestation of BPDCN often consists of cutaneous lesions. In...… CME-Test
View Post 5 min This content is machine translated Paroxysmal nocturnal hemoglobinuria Real-world data on thrombosis predictors and C5 complement inhibitors Paroxysmal nocturnal haemoglobinuria (PNH) is a rare, acquired disease of haematopoietic stem cells of the bone marrow. GPI deficiency results in the absence of complement-regulating proteins. Thromboembolic complications are the...…
View Post 3 min This content is machine translated Follow-up care for head and neck cancer What is the significance of FDG PET-CT? Imaging plays an important role in the aftercare of head and neck tumors. Regular FDG PET-CT examinations can detect recurrences or metastases at an early stage. In the presence of...…
